Transthyretin Amyloidosis Clinical Trial
Official title:
Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology
Familial amyloid neuropathy due to transthyretin gene mutations (TTR-FAP) is a rare autosomal dominant inherited disease resulting in the abnormal multi-system deposition of amyloid proteins. These deposits produce a multi-organ disease. AP is usually fatal 10 to 15 years after onset of symptoms if untreated. The prevalence of the disease remains still poorly understood and usually the search for this pathology is done in a third line of investigation. So the average time to diagnosis is extremely long, from 12 to 24 month. Now that the investigators have etiological treatment ( famidis (Vyndaqel®) and Diflunisal (Dolobid)) of this disease, it is essential to be able to detect FAP patients as early as possible. With this study, investigator decided to test for TTR mutation all patients presented with neuropathy of unknown etiology at the first line of investigation. The goal of this study is to evaluate the prevalence of FAP-TTR among neuropathy and defined the best strategy to test this population for TTR mutations.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03588468 -
Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
|
N/A | |
| Completed |
NCT03591757 -
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
|
Early Phase 1 | |
| Completed |
NCT05075798 -
Study of Cerebral MRI Anomalies in Mutated Transthyretin Amyloidosis Patients
|
||
| Recruiting |
NCT05577819 -
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
|
N/A | |
| Terminated |
NCT04611204 -
Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery
|
||
| Recruiting |
NCT03352089 -
Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis
|
N/A | |
| Recruiting |
NCT05814380 -
The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis.
|
||
| Completed |
NCT03886155 -
Cardiac Amyloidosis Screening at Trigger Finger Release
|
||
| Completed |
NCT03923920 -
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
|
||
| Completed |
NCT03862807 -
Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant
|
Phase 3 | |
| Completed |
NCT02792790 -
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
|
||
| Completed |
NCT03860935 -
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
|
Phase 3 | |
| Recruiting |
NCT04963985 -
The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients
|
Phase 4 | |
| Recruiting |
NCT05409833 -
Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population
|
||
| Recruiting |
NCT05635045 -
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
|
Phase 2 | |
| Completed |
NCT01171859 -
Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis
|
Phase 2 | |
| Recruiting |
NCT03237494 -
TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects
|
||
| Recruiting |
NCT04899180 -
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
|
Early Phase 1 | |
| Recruiting |
NCT06345235 -
New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis
|
||
| Completed |
NCT00628745 -
Transthyretin Amyloidosis Outcome Survey (THAOS)
|